Home › Funds › UNIVERSITY OF CHICAGO › PYXS

UNIVERSITY OF CHICAGO position in PYXS

PYXIS ONCOLOGY INC · Health Care

UNIVERSITY OF CHICAGO reported holding 48,731 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$114K, representing 0.03% of its reported portfolio and ranking #10 among its reported holdings. UNIVERSITY OF CHICAGO has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)48.73K sh
Reported value held$113.54K
Portfolio Weight0.03%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How UNIVERSITY OF CHICAGO's PYXS position evolved

UNIVERSITY OF CHICAGO first disclosed a stake in PYXS in Q3 2023 at 48,731 shares (US$97K). The position peaked in Q1 2024 at 48,731 shares, worth US$208K. Across 13 filings, UNIVERSITY OF CHICAGO held the position steady without any share-count change. The most recent filing (Q3 2026) shows 48,731 shares valued at US$114K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 48.73K $96.97K New
Q4 2023 48.73K $87.72K Hold
Q1 2024 48.73K $207.59K Hold
Q2 2024 48.73K $161.30K Hold
Q3 2024 48.73K $178.84K Hold
Q4 2024 48.73K $76.02K Hold
Q1 2025 48.73K $47.75K Hold
Q2 2025 48.73K $53.60K Hold
Q3 2025 48.73K $108.18K Hold
Q4 2025 48.73K $56.04K Hold
Q1 2026 48.73K $71.15K Hold
Q2 2026 48.73K $146.68K Hold
Q3 2026 48.73K $113.54K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PYXS and 13F data

PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 33 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PYXS

All PYXS fund holders →

FAQ

How long has UNIVERSITY OF CHICAGO held PYXS?

UNIVERSITY OF CHICAGO has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is UNIVERSITY OF CHICAGO's current position in PYXS?

As of Q3 2026, UNIVERSITY OF CHICAGO holds 48.73K shares of PYXS (PYXIS ONCOLOGY INC), valued at $113.54K, representing 0.03% of its reported portfolio and ranking #10.

Has UNIVERSITY OF CHICAGO been buying or selling PYXS?

In the latest 13F filing (Q3 2026), UNIVERSITY OF CHICAGO held unchanged its position in PYXS. The position peaked in Q1 2024 at 48.73K shares.

Which other funds hold PYXS?

Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.